Journal article

A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy

Devy Deliyanti, Jae Young Lee, Steven Petratos, Colin J Meyer, Keith W Ward, Jennifer L Wilkinson-Berka, Judy B de Haan

Clinical Science | PORTLAND PRESS LTD | Published : 2016

Grants

Awarded by Trish Multiple Sclerosis Research Foundation


Awarded by National Multiple Sclerosis Society


Funding Acknowledgements

This work was supported by the Multiple Sclerosis Research Australia Postgraduate Scholarship (to J.Y.L.); the Trish Multiple Sclerosis Research Foundation [grant number #12-060 (to J.Y.L.)]; the National Multiple Sclerosis Society Project [grant number RG4398A1/1 (to S.P.)]; the Reata Pharmaceuticals, Inc. (to J.B.dH.); and the Victorian Government's Operational Infrastructure Support Program.